UPDATE 1-Momenta sues Teva over generic Lovenox

* Momenta accuses Teva of patent infringement

* Momenta shares up 0.6 pct, Teva shares rise 0.5 pct

NEW YORK, Dec 2 (BestGrowthStock) – Momenta Pharmaceuticals Inc
(MNTA.O: ) said it has sued Teva Pharmaceutical Industries Ltd
(TEVA.TA: ), accusing the company of infringing its patents on
production and processing of the blood thinner enoxaparin.

In July Momenta won U.S. approval to sell the first generic
formulation of the injectable drug. The branded product,
Lovenox, is sold by Sanofi-Aventis SA (SASY.PA: ) and long has
been used in hospitals to treat and prevent blood clots.

Momenta sells its generic in partnership with the Sandoz
generic drug division of Swiss drugmaker Novartis AG
(NOVN.VX: ).

Momenta shares were up 0.6 percent in early trading in New
York. Teva shares rose 0.5 percent.
(Reporting by Ransdell Pierson; editing by John Wallace)

UPDATE 1-Momenta sues Teva over generic Lovenox